Insights from atrial surface activation throughout atrial tachycardia cycle length: A new mapping tool.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
11 2019
Historique:
received: 07 02 2019
pubmed: 21 4 2019
medline: 15 12 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

A novel "LUMIPOINT" software in the Rhythmia system (Boston Scientific) displays a histogram of activated area over the entire atrial tachycardia (AT) cycle length (CL) with a normalized score. The purpose of this study was to examine whether the pattern of this global activation histogram (GAH) identified reentrant vs focal AT and whether a decrease in atrial activation area, shown as valleys in the GAH, identifies isthmuses. One hundred eight activation maps of ATs (17 focal, 57 macroreentrant, 21 localized, 13 multiple loop) in 67 patients were reviewed retrospectively with the LUMIPOINT software. The ACTIVATION SEARCH feature highlighted the activated area in a given time period irrespective of the activation map. A 30-ms unit time interval was set, and the GAH patterns and electrophysiological properties of highlighted areas were examined. Focal ATs systematically displayed a plateau with GAH-Score <0.1 for at least 30% of the CL. Most reentrant ATs (90/91 [98.9%]) lacked this plateau and displayed activity covering the entire CL, with 2 [1-2] GAH-Valleys per tachycardia. Each GAH-Valley highlighted 1 [1-2] areas in the map. Among 264 highlighted areas, 198 (75.0%) represented slow conduction, 19 (7.2%) lines of block, 27 (10.2%) wavefront collision, 3 (1.1%) unknown, and 17 (6.4%) absence of activation in focal ATs. Practical ablation sites all matched one of the highlighted areas based on GAH-Valleys, and they corresponded better with areas highlighted by GAH-Score ≤0.2 (P <.0001). GAH shows focal vs reentrant mechanisms at first glance. Decrease in activated areas (displayed by GAH-Valleys) is mostly due to slow conduction and highlights areas of special interest, with 100% sensitivity for isthmus identification.

Sections du résumé

BACKGROUND
A novel "LUMIPOINT" software in the Rhythmia system (Boston Scientific) displays a histogram of activated area over the entire atrial tachycardia (AT) cycle length (CL) with a normalized score.
OBJECTIVE
The purpose of this study was to examine whether the pattern of this global activation histogram (GAH) identified reentrant vs focal AT and whether a decrease in atrial activation area, shown as valleys in the GAH, identifies isthmuses.
METHODS
One hundred eight activation maps of ATs (17 focal, 57 macroreentrant, 21 localized, 13 multiple loop) in 67 patients were reviewed retrospectively with the LUMIPOINT software. The ACTIVATION SEARCH feature highlighted the activated area in a given time period irrespective of the activation map. A 30-ms unit time interval was set, and the GAH patterns and electrophysiological properties of highlighted areas were examined.
RESULTS
Focal ATs systematically displayed a plateau with GAH-Score <0.1 for at least 30% of the CL. Most reentrant ATs (90/91 [98.9%]) lacked this plateau and displayed activity covering the entire CL, with 2 [1-2] GAH-Valleys per tachycardia. Each GAH-Valley highlighted 1 [1-2] areas in the map. Among 264 highlighted areas, 198 (75.0%) represented slow conduction, 19 (7.2%) lines of block, 27 (10.2%) wavefront collision, 3 (1.1%) unknown, and 17 (6.4%) absence of activation in focal ATs. Practical ablation sites all matched one of the highlighted areas based on GAH-Valleys, and they corresponded better with areas highlighted by GAH-Score ≤0.2 (P <.0001).
CONCLUSION
GAH shows focal vs reentrant mechanisms at first glance. Decrease in activated areas (displayed by GAH-Valleys) is mostly due to slow conduction and highlights areas of special interest, with 100% sensitivity for isthmus identification.

Identifiants

pubmed: 31004777
pii: S1547-5271(19)30358-3
doi: 10.1016/j.hrthm.2019.04.029
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1652-1660

Informations de copyright

Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Masateru Takigawa (M)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France; Heart Rhythm Center, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: teru.takigawa@gmail.com.

Claire A Martin (CA)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France; Royal Papworth Hospital, Cambridge, United Kingdom.

Nicolas Derval (N)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Arnaud Denis (A)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Konstantinos Vlachos (K)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Takeshi Kitamura (T)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Antonio Frontera (A)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Ruairidh Martin (R)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France; Royal Papworth Hospital, Cambridge, United Kingdom.

Ghassen Cheniti (G)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Anna Lam (A)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Felix Bourier (F)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Nathaniel Thompson (N)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Michael Wolf (M)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Grégoire Massoulié (G)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

William Escande (W)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Clementine Andre (C)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Li Jun Zeng (LJ)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Yosuke Nakatani (Y)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Jean-Rodolphe Roux (JR)

Boston Scientific, Paris, France.

Josselin Duchateau (J)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Thomas Pambrun (T)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Frederic Sacher (F)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Hubert Cochet (H)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Meleze Hocini (M)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Michel Haissaguerre (M)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Pierre Jais (P)

Hôpital Cardiologique Haut Lévêque, Lyric Institute, Université de Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH